Quantitation and distribution of vitronectin in synovial fluid and tissue of patients with rheumatic disease

Clinical and Experimental Rheumatology

Volumn 14, Issue 1, 1996, Pages 31-36

  Rosenblum, G ^a,c   Carsons, S ^b  

^a Department of Medicine ^*  (United States)

^b Allerg Immunol Schering Plough R   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

adhesion proteins; synovial fluid; vitronectin

Indexed keywords

VITRONECTIN;

ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ARTHRITIS, RHEUMATOID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; OSTEOARTHRITIS; RHEUMATIC DISEASES; SYNOVIAL FLUID; VITRONECTIN;

EID: 0030011979     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. REILLY JT, NASH JR: Vitronectin (serum spreading factor): its localization in normal and fibrotic tissue. J Clin Pathol 1988; 41: 1269-72.
2. PREISSNER KT, DIETER J: Structure of vitronectin and its biological role in hemostasis. Thrombosis Haemostasis 1991; 66: 123-32.
3. POHL WR, CONLAN MG, THOMPSON AB, ERTL RF, RONNBERGER DJ, MOSHER DF, RENNARD SI: Vitronectin in broncoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis 1991; 143: 1369-75.
4. DEMAZIERE A, ATHMASOU NA: Adhesion receptors of intimai and subintimal cells of the normal synovial membrane. J Pathol 1992; 168: 209-15.
5. HAYMAN EG, PIERSCHBACHER MD, SUZUKI S, RUOSLAHTI E: Vitronectin - a major cell attachment promoting protein in fetal bovine serum. Exp Cell Res 1985; 160: 245-58.
6. PODACK ER, MUELLER-EBERHARD HJ: Isolation of human S-protein and inhibition of the membrane attack complex of complement. J Biol Chem 1979; 254: 9907.
7. TOMASINI BR, MOSHER DF: On the identity of vitronectin and S-protein: Immunological cross-reactivity and functional studies. Blood 1986; 68: 737-42.
8. 3b. Blood 1988; 71: 86-93.
9. SAVILL J, DRANSFIELD I, HOGG N, HASLETT C: Vitronectin receptor mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343: 170-3.
10. FADOK VA, SAVILL JS, HASLETT C, BRATTON DL, DOHERTY PE, CAMPBELL PA, HENSON PM: Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-35.
11. PREISSNER KT: Specific binding of plasminogen to vitro-nectin. Biochem Biophys Res Comm 1990; 168: 966-71.
12. PREISSNER KT, HOLZHUTER S, JUSTUS C, MUELLER-BERGHAUS G: Identification and partial characterization of platelet vitronectin: Evidence for complex formation with platelet derived PAI-1. Blood 1989; 74: 1989-96.
13. GECHTMAN Z, SHARMA R, KREIZMAN T: Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin. FEBS Lett 1993; 315: 293-7.
14. ROPES MW, BAUER W: Synovial Fluid Changes in Joint Disease. Cambridge, Harvard University Press, 1953.
15. NETTLEBLADT E, SUNBLAD L, JONSSON E: Permeability of the synovial membranes to proteins. Acta Rheum Scand 1963; 9: 28.
16. CARSONS SE, MOSESSON MW, DIAMOND HS: Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease. Arthritis Rheum 1981; 24: 1261.
17. CONLAN MG, TOMASINI BR, SCHULTZ RL, MOSHER DF: Plasma vitronectin in normal subjects and patients with disseminated intravascular coagulation. Blood 1988; 72: 185.
18. CARSONS SE: Fibronectin in Health and Disease. CRC Press, Inc. 1989.
19. BERNARD BA, YAMADA KM, OLDEN K: Carbohydrates selectively protect a specific domain of fibronectin against proteases. J Biol Chem 1982; 257: 8549.
20. ASHTON BA, ASHTON IK, MARSHALL MJ, BUTLER RC: Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis. Ann Rheum Dis 1993; 52: 133-7.